Lilly: New phase 3b data for Taltz and Zepbound together vs Taltz alone
TradeXchange reports Lilly’s phase 3b results on Taltz and Zepbound together, showing broader biomarker changes versus Taltz alone, in adults with psoriasis and obesity.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Eli Lily: Taltz And Zepbound Together Show Broader Biomarker Changes Vs. Taltz Alone
New Phase 3b Data On Lilly's Taltz And Zepbound Advance Understanding Of The Interconnected Immune And Metabolic Biology In Adults With Psoriasis And Obesity